Stanford scientists have developed Q-DOAS (Quantitative Detection of Oligomer and Amyloid Seeds), a plate reader-based fluorescence quenching assay designed to track the formation of early-stage toxic oligomers and amyloid seeds in real-time.
Stanford researchers have developed a novel therapeutic approach for neurodegenerative diseases by targeting endoplasmic reticulum (ER) stress in neurons using CHOP inhibitors, with significant potential for development into first-in-class neuroprotective drugs for neurodegene
Stanford scientists have developed PVSeg, a tool that automatically segments vascular and perivascular compartments in brain MRI data. This innovative tool can identify non-demented individuals at increased risk of developing dementia and accelerated brain atrophy.
Stanford scientists have developed a device to distinguish the molecule-specific signatures of diseased exosomes isolated from glioblastoma patients. The device is portable, disposable, and low-cost, enabling point-of-care assessment of disease.